According to the CDC, heart disease is the leading cause of death in America going all the way back to the 1950's, and while people have become familiar with genetic testing for cancer risk, our Joe Kwan tells us about a test for cardiovascular health that is linked to what is in your genes. Watch the story on Youtube.
Precision4Me, an AI-powered tool used at Providence's Orange County hospitals, is helping to improve early cancer screenings
Prevention4Me - Genetic Cancers Providence is helping women proactively manage their cancer risk by participating in the Prevention4Me program.
Longitudinal multiomics profiling of extracorporeal cross-circulation with pig liver xenografts in human decedents
Early Diagnosis and Precision Genomics Help Reverse a Rare, Life-Threatening Cancer Complication
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma
How ProvSeq biomarker testing helped change this patient’s cancer journey
The goal is to create a digital representation—or medical twin—of a patient and use advanced AI to understand what treatments work best and provide more informed options about the most effective paths
Published in JAMA Network Open, a new Providence study uses real-world data to show how AI ambient listening reduces documentation burden, improving efficiency and clinician focus on patient care.
Providence is joining a nationwide, federally funded research project to develop a Large Health Behavior Model.
Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.
A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.
Findings suggest that while outreach yields low engagement, low-cost methods such as email are feasible, and point-of-care access is critical for improving participation and equity. Health systems sho
Researchers from Providence, the University of Washington, and Microsoft developed GigaTIME, a publicly available AI model that generates spatial proteomic images at scale.
A research team from Renton, Wash based Providence has launched an interactive toolkit to help health systems boost equity in medical research.
Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients
